Tirupati Medilines Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.11 M
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.05 Cr
- Revenue Growth 69.59%
- Profit Growth 104.36%
- Ebitda 69.61%
- Net Worth 52.78%
- Total Assets 40.29%
About Tirupati Medilines
Tirupati Medilines Private Limited (TMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 October 2011 and has a history of 13 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹2.05 Cr.
Mudit Gupta and Shubham Gupta serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397DL2011PTC226590
-
Company No.
226590
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Oct 2011
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Tirupati Medilines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mudit Gupta
|
Director | 28-Oct-2020 | Current |
|
Shubham Gupta
|
Director | 31-Mar-2021 | Current |
Financial Performance of Tirupati Medilines.
Tirupati Medilines Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 69.59% increase. The company also saw a substantial improvement in profitability, with a 104.36% increase in profit. The company's net worth Soared by an impressive increase of 52.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tirupati Medilines?
In 2021, Tirupati Medilines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Sep 2020 | Axis Bank Limited | ₹2.05 Cr | Open |
How Many Employees Work at Tirupati Medilines?
Unlock and access historical data on people associated with Tirupati Medilines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tirupati Medilines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tirupati Medilines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
